Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Assessment of the Alamar Blue assay for cellular growth and viability in vitro.

Literature DB >> 9212838

Assessment of the Alamar Blue assay for cellular growth and viability in vitro.

G R Nakayama, M C Caton, M P Nova, Z Parandoosh.

Abstract

Mesh：

Substances：

Year: 1997 PMID： 9212838 DOI： 10.1016/s0022-1759(97)00043-4

Source DB: PubMed Journal: J Immunol Methods ISSN： 0022-1759 Impact factor: 2.303

Keyword Cloud
Cited

× No keyword cloud information.

130 in total

1. Biochemical analysis of PIFTC3, the Trypanosoma brucei orthologue of nematode DYF-13, reveals interactions with established and putative intraflagellar transport components.

Authors: Joseph B Franklin; Elisabetta Ullu
Journal: Mol Microbiol Date: 2010-10 Impact factor: 3.501

2. Hydrogen sulphide-releasing diclofenac derivatives inhibit breast cancer-induced osteoclastogenesis in vitro and prevent osteolysis ex vivo.

Authors: J Frantzias; J G Logan; P Mollat; A Sparatore; P Del Soldato; S H Ralston; A I Idris
Journal: Br J Pharmacol Date: 2012-03 Impact factor: 8.739

3. Microarray analysis of nemorosone-induced cytotoxic effects on pancreatic cancer cells reveals activation of the unfolded protein response (UPR).

Authors: Frank Holtrup; Andrea Bauer; Kurt Fellenberg; Ralf A Hilger; Michael Wink; Jörg D Hoheisel
Journal: Br J Pharmacol Date: 2011-03 Impact factor: 8.739

4. Kinase requirements in human cells: II. Genetic interaction screens identify kinase requirements following HPV16 E7 expression in cancer cells.

Authors: Amy Baldwin; Wenliang Li; Miranda Grace; Joseph Pearlberg; Ed Harlow; Karl Münger; Dorre A Grueneberg
Journal: Proc Natl Acad Sci U S A Date: 2008-10-23 Impact factor: 11.205

5. Anti-inflammatory activity of nanoemulsions of essential oil from Rosmarinus officinalis L.: in vitro and in zebrafish studies.

Authors: Raphaelle Sousa Borges; Hady Keita; Brenda Lorena Sánchez Ortiz; Tafnis Ingret Dos Santos Sampaio; Irlon Maciel Ferreira; Emerson Silva Lima; Márcia de Jesus Amazonas da Silva; Caio Pinho Fernandes; Anna Eliza Maciel de Faria Mota Oliveira; Edemilson Cardoso da Conceição; Alex Bruno Lobato Rodrigues; Arlindo César Matias Pereira Filho; Andrés Navarrete Castro; José Carlos Tavares Carvalho
Journal: Inflammopharmacology Date: 2018-02-05 Impact factor: 4.473

6. A porous scaffold for bone tissue engineering/45S5 Bioglass derived porous scaffolds for co-culturing osteoblasts and endothelial cells.

Authors: Sanjukta Deb; Ramin Mandegaran; Lucy Di Silvio
Journal: J Mater Sci Mater Med Date: 2009-11-29 Impact factor: 3.896

Assessment of the Alamar Blue assay for cellular growth and viability in vitro.

1. Biochemical analysis of PIFTC3, the Trypanosoma brucei orthologue of nematode DYF-13, reveals interactions with established and putative intraflagellar transport components.

2. Hydrogen sulphide-releasing diclofenac derivatives inhibit breast cancer-induced osteoclastogenesis in vitro and prevent osteolysis ex vivo.

3. Microarray analysis of nemorosone-induced cytotoxic effects on pancreatic cancer cells reveals activation of the unfolded protein response (UPR).

4. Kinase requirements in human cells: II. Genetic interaction screens identify kinase requirements following HPV16 E7 expression in cancer cells.

5. Anti-inflammatory activity of nanoemulsions of essential oil from Rosmarinus officinalis L.: in vitro and in zebrafish studies.

6. A porous scaffold for bone tissue engineering/45S5 Bioglass derived porous scaffolds for co-culturing osteoblasts and endothelial cells.

7. Labelling of mammalian cells for visualisation by MRI.

Review 8. No time to lose--high throughput screening to assess nanomaterial safety.

9. Genistein at maximal physiologic serum levels induces G0/G1 arrest in MCF-7 and HB4a cells, but not apoptosis.

10. Formation of highly adherent nano-porous alumina on Ti-based substrates: a novel bone implant coating.